Prognostic value of body composition on early recurrence and long-term survival of resectable pancreatic ductal adenocarcinoma
Open Access
- 10 November 2025
- journal article
- hepatobiliary pancreas
- Published by Springer Nature in European Radiology
- Vol. 36 (4) , 2945-2964
Abstract
Objective: To explore the associations of CT-evaluated body composition with early recurrence (ER) and overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC) after resection. Materials and methods: A retrospective analysis was performed on consecutively enrolled patients who underwent surgical resection for PDAC between 2014 and 2023. Patients were divided into a training set ( n = 412) and a validation set ( n = 120). Sex-specific cutoff values were determined for body composition indices, including visceral-to-subcutaneous fat ratio (VSR), skeletal muscle density (SMD), subcutaneous fat area (SFA), and other metrics. Logistic regression and Cox proportional hazards models were used to analyze the associations of body composition with ER and OS. Subgroup analyses were conducted based on clinicopathological characteristics to explore the prognostic value of body composition. Results: High VSR was an independent predictor for ER (OR: 2.304, p = 0.001) and worse OS (HR: 1.462, p = 0.007), whereas high SMD (HR: 0.609, p = 0.005) and high SFA (HR: 0.649, p = 0.002) were independent predictors for better OS. Subgroup analyses revealed variations in the prognostic effect of VSR according to diabetes status and tumor size. A model combining body composition metrics and clinicopathological indicators (carbohydrate antigen 19-9, carbohydrate antigen 12-5, tumor-node-metastasis stage, lymphovascular invasion, and adjuvant therapy) demonstrated good predictive ability for ER, with AUCs of 0.80 in the training set and 0.82 in the validation set. Conclusion: High VSR was an independent predictor for ER and worse OS in PDAC. Moreover, combining body composition metrics and clinicopathological indicators can improve the prognosis prediction of patients with PDAC after surgery. Key Points: Question What are the associations of CT-evaluated body composition with early recurrence and overall survival in patients with pancreatic ductal adenocarcinoma after resection? Findings High visceral-to-subcutaneous fat ratio is an independent predictor for early recurrence, whereas high skeletal muscle density and subcutaneous fat area independently predict better overall survival . Clinical relevance Combining body composition and clinicopathological indicators (carbohydrate antigen 19-9, carbohydrate antigen 12-5, tumor-node-metastasis stage, lymphovascular invasion, and adjuvant therapy) enables reliable prediction of postoperative prognosis in pancreatic ductal adenocarcinoma patients . GraphicalKeywords
Funding Information
- National Key Research and Development Program of China (2023YFC2413500)
- National Natural Science Foundation of China (82302313)
- National Natural Science Foundation of China (82402411)
This publication has 41 references indexed in Scilit:
- Prognostic value of deep learning-derived body composition in advanced pancreatic cancer—a retrospective multicenter studyESMO Open, 2024
- Body composition parameters predict survival in pancreatic cancer—A retrospective multicenter analysisUnited European Gastroenterology Journal, 2023
- Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After HepatectomyAcademic Radiology, 2023
- Inflammation in obesity, diabetes, and related disordersImmunity, 2022
- Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancerEuropean Radiology, 2021
- Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomyEuropean Radiology, 2020
- Lipids in the tumor microenvironment: From cancer progression to treatmentProgress in Lipid Research, 2020
- Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapyThe Breast, 2017
- Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancerJournal of Cachexia, Sarcopenia and Muscle, 2016
- Lipolytic and thermogenic depletion of adipose tissue in cancer cachexiaSeminars in Cell & Developmental Biology, 2016